We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.22B
AUM Growth
-$1.2B
Cap. Flow
-$1.32B
Cap. Flow %
-31.23%
Top 10 Hldgs %
40.53%
Holding
893
New
143
Increased
129
Reduced
82
Closed
273
Avg Time Held Equity + Options
3.6 quarters
Top 10 Avg Time Held Equity + Options
0.7 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.7 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Top Buys

Rank Stock Value
1
OSH
Oak Street Health, Inc.
OSH
+$211M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$189M
3
UNVR
Univar Solutions Inc.
UNVR
+$175M
4
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$143M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$137M

Top Sells

Rank Stock Value
1
STOR
STORE Capital Corporation
STOR
+$414M
2
LHCG
LHC Group LLC
LHCG
+$211M
3
ATVI
Activision Blizzard
ATVI
+$196M
4
SGFY
Signify Health, Inc.
SGFY
+$161M
5
ONEM
1Life Healthcare
ONEM
+$141M

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.3%
3 Technology 18.64%
4 Miscellaneous 15.12%
5 Industrials 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
NNN icon
276
NNN REIT
NNN
$7.71B
$2.24M 0.05%
50,648
+34,005
+204% +$1.55M
2021 Q4
5 quarters
FNVT icon
277
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
$2.22M 0.05%
212,681
– –
2021 Q4
5 quarters
BPMC icon
278
DELISTED
Blueprint Medicines
BPMC
$2.21M 0.05%
49,233
+7,627
+18% +$344K
2022 Q4
1 quarter
DNAD
279
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$2.21M 0.05%
216,014
– –
2021 Q2
7 quarters
KIDS icon
280
OrthoPediatrics
KIDS
$571M
$2.2M 0.05%
49,646
+6,364
+15% +$281K
2022 Q1
4 quarters
CITE icon
281
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$2.2M 0.05%
208,518
– –
2022 Q2
3 quarters
MRUS icon
282
DELISTED
Merus
MRUS
$2.12M 0.05%
115,080
+50,780
+79% +$885K
2022 Q1
4 quarters
SPEC icon
283
DELISTED
Spectaire Holdings, Inc. Common Stock
SPEC
$2.11M 0.05%
198,893
-278,353
-58% -$2.92M
2022 Q1
4 quarters
GMFI icon
284
DELISTED
Aetherium Acquisition Corp
GMFI
$2.1M 0.05%
201,057
– –
2022 Q1
4 quarters
RCUS icon
285
Arcus Biosciences
RCUS
$3.12B
$2.09M 0.05%
114,480
+87,655
+327% +$1.68M
2022 Q2
3 quarters
ORIC icon
286
Oric Pharmaceuticals
ORIC
$1.24B
$2.07M 0.05%
362,707
+17,272
+5% +$90.3K
2022 Q2
3 quarters
NVDA icon
287
NVIDIA
NVDA
$5.51T
$2.03M 0.05%
+73,260
New +$1.59M
2023 Q1
0 quarters
DYN icon
288
Dyne Therapeutics
DYN
$3.1B
$2.03M 0.05%
176,601
-31,590
-15% -$410K
2022 Q1
4 quarters
MORN icon
289
Morningstar
MORN
$7.79B
$2.03M 0.05%
+10,000
New +$2.2M
2023 Q1
0 quarters
MDT icon
290
Medtronic
MDT
$117B
$2.02M 0.05%
+25,000
New +$2.04M
2023 Q1
0 quarters
AMD icon
291
Advanced Micro Devices
AMD
$975B
$2.01M 0.05%
+20,536
New +$1.67M
2023 Q1
0 quarters
ESTA icon
292
Establishment Labs
ESTA
$1.84B
$1.98M 0.05%
29,189
+1,390
+5% +$95.3K
2022 Q1
4 quarters
HLN icon
293
Haleon
HLN
$41.1B
$1.97M 0.05%
241,662
+11,508
+5% +$91.7K
2022 Q3
2 quarters
VRNA
294
DELISTED
Verona Pharma
VRNA
$1.96M 0.05%
97,572
-31,354
-24% -$677K
2022 Q3
2 quarters
FRBN
295
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
$1.95M 0.05%
185,349
– –
2022 Q2
3 quarters
BLU
296
DELISTED
BELLUS Health Inc.
BLU
$1.95M 0.05%
271,161
+6,912
+3% +$53.6K
2022 Q1
4 quarters
IRTC icon
297
iRhythm Holdings
IRTC
$3.48B
$1.95M 0.05%
+15,715
New +$1.7M
2023 Q1
0 quarters
HCMA icon
298
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
$1.95M 0.05%
185,349
– –
2022 Q1
4 quarters
KROS icon
299
Keros Therapeutics
KROS
$236M
$1.94M 0.05%
45,484
+166
+0.4% +$8.38K
2022 Q1
4 quarters
WEL icon
300
DELISTED
Integrated Wellness Acquisition Corp
WEL
$1.92M 0.05%
185,349
– –
2022 Q1
4 quarters
10 11
12
13 14

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 893 positions worth $4.22B, down 22% from $5.42B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $1.32B in Q1 2023, closing 273 positions and reducing 82 holdings. Its most notable exit was STORE Capital Corporation, an estimated $414M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

Against the trend, UBS O'Connor opened a new position in Oak Street Health, Inc. worth $25.3M.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited STORE Capital Corporation in Q1 2023, selling an estimated $414M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 143 new positions and closed 273 in Q1 2023.
  • UBS O'Connor's portfolio value fell 22% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.